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Bone resorption stimulated by elevated serum 1,25-(OH)2-vitainin D
concentrations in healthy men. We evaluated whether calcitriol adminis-
tration to healthy men stimulates bone resorption. We compared serum
1,25-(0H)2-D concentrations, Ca and P04 balances, and urinary hy-
droxyproline excretion rates in four healthy men adapted to a low Ca
diet providing only 4.0 0.2 so mmoles Calday to those in four healthy
men eating a comparable diet (4.2 0.9 mmoles Ca/day) during the
chronic oral administration of calcitriol. 0.75 jsg every 6 hr. Serum 1,25-
(0H)2-D levels averaged 94 16 p during the control studies and 209
35 pM during calcitriol administration. Net intestinal Ca absorption
averaged 0.5 0.3 mmoles/day during control and 1.8 0.5 mmoles/
day during calcitriol (P < 0.005), but urinary Ca excretion averaged 8.7
2.0 mmoles/day during calcitriol as compared to 2.9 1.4 mmoles/
day during control (P < 0.005). Thus, mean Ca balance, which averaged
—2.4 1.2 mmoles/day during control, was more negative during
calcitriol at —6.3 2.4 mmo!es/day (P < 0.05). Average daily P04
balances averaged +7.7 1.5 mmoles/day during control but only
tended to be negative during calcitriol at —1 1 5.4 mmoles/day, (NS).
Urinary hydroxyproline excretion averaged 0.26 0.03 mmoles/day
during control and 0.49 0.06 during calcitriol (P < 0.001). We
conclude that elevated serum l.25-(OH)2-D concentrations in healthy
men eating low Ca diets stimulate bone resorption.
La resorption osseuse stimulé par des concentrations elevées de 1,25-
(OH)2-vitamine D chez des hommes normaux. Nous avons recherché si
I'administration de calcitriol a des hommes normaux stimule Ia rCsorp-
tion osseuse. Nous avons compare les concentrations sériques de 1,25-
(0H)2-D, les balances de Ca et P04 et l'excrétion urinaire d'hydroxy-
proline chez quatre hommes normaux adaptés it un régime pauvre en Ca
apportant seulement 4,0 0,2 so mmoles Ca/jour it ceux de quatre
hommes normaux consommant un régime comparable (4,2 0,9
mmoles Ca/jour) pendant I'administration orale chronique de calcitriol,
0,75 tg toutes les 6 heures. Les concentrations sériques de l,25-(0H)2-
D étaient en moyenne de 94 16 M pendant les etudes contrôles et de
209 35 pM pendant l'administration de calcitriol. L'absorption
intestinale nette de Ca était en mocine de 0,5 0,3 mmoles/jour
pendant le contrôle et de 1,8 0,5 mmoles/jour pendant Ia prise de
calcitriol (P < 0,005), mais l'excrétion ut-inaire de Ca était en moyenne
de 8,7 2,0 mmoles/jour pendant Ic calcitriol, par rapport a 2,9 1,4
mmoles/jour pendant Ic contrOle (P < 0,005). Ainsi, Ia balance moyenne
de Ca, qui était en moyenne de —2,4 1,2 mmoles/jour pendant Ic
contrôle, était encore plus negative pendant le calcitriol, de —6,3 2,4
mmoles/jour (P < 0,05). Les balances moyennes journalières de PU4
étaient de +7,7 1,5 mmoles/jour pendant Ic contrôle, mais n'avaient
que simplement tendance it étre negatives pendant le calcitriol it —1,1
5,4 mmotes/jour, (NS). L'excrétion urinaire d'hydroxyproline était de
0,26 0,03 mmoles/jour pendant le contrôle et de 0,49 0,06 pendant
le calcitriol (P < 0,001). Nous concluons que les concentrations élevdes
de I ,25-(OH)2-D serique chez des hommes normaux consommant des
regimes pauvres en calcium stimulent Ia resorption osseuse.
Currently available data indicate that l,25-(OH)2-D is the
major, if not the sole, hormonal stimulus for intestinal calcium
(Ca) absorption in animals [1, 2] and in humans [3—5]. 1,25-
(OH)2-D is also capable of stimulating bone resorption in
animals both in vivo and in vitro [6, 7]. We have observed that
the administration of 1 ,25-(OH)2-D to healthy men eating a low
Ca diet produced average daily urinary Ca excretion rates in
excess of dietary Ca intake [8]. This observation is consistent
with the view that I ,25-(OH)2-D can stimulate bone resorption
in humans. However, the brevity of those studies did not permit
measurements of intestinal Ca absorption. Therefore, those
studies did not completely exclude the possibility that the extra
urinary Ca might simply represent enhanced intestinal Ca
absorption. We have now observed Ca and phosphate (P04)
balances in healthy men adapted to a low Ca diet to minimize
expression of the effect of 1 ,25-(OH)2-D to augment intestinal
Ca absorption. These data have been compared to studies in
healthy men eating the same diet while chronically receiving
calcitriol. The elevated serum I ,25-(OH)2-D concentrations
achieved during chronic calcitriol administration were associat-
ed with hypercalciuria, more negative Ca balance, and in-
creased urinary hydroxyproline excretion. These results pro-
vide further evidence to support the view that 1 ,25-(OH)2-D can
stimulate bone resorption in humans.
Methods
Metabolic balance studies were carried out in eight healthy
men in the Medical College of Wisconsin Clinical Research
Center, Milwaukee, Wisconsin, with their consent and the
approval of the Medical College of Wisconsin Human Research
Review Committee. All studies were performed while the
subjects ate constant whole food diets low in Ca. Because of the
length of the studies, two diets of nearly identical composition
were alternated daily. The average daily diet provided: Ca 4.1
0.8 mmoles/day, P04 52.8 5.2 mmoles/day, Mg 17.4 1.4
mmoles/day, K 75 5 mmoles/day, Na 138 14 mmoles/day,
and Cl 119 9 mmoles/day. The diets provided an average of
2840 270 calories, 54 3% as carbohydrate, 13 1% as
protein, and the remainder as fat. The diets did not contain
gelatin. Four subjects were adapted to the low Ca diet for 4 days
and then observed during two 6-day control balance periods.
555
Received for publication July 2, 1982
and in revised form March 16, 1983
© 1983 by the International Society of Nephrology
556 Maierhofer et a!
£ *
* *** .*
—. •*.t *
ee
•••***. • •** • • •*
* 0• *S**
*S
0.
•
00 ••
•,•.
• •S * * *S*,**, *0.
•• *
•
•,
***
,
Four subjects were begun on the low Ca diet together with oral
calcitriol, 0.75 jg every 6 hr (6 A.M., 12 P.M., 6 P.M., 12 A.M.).
After 4 days of adaptation to this regimen, three 6-day balance
periods were observed. Carmine markers were used to separate
the stool periods.
Duplicate diets were analyzed for mineral content. Although
carmine markers were used to separate 6-day stool periods,
feces were pooled for analysis every ito 3 days to permit more
frequent estimation of mineral excretion in the feces and net
intestinal mineral absorption. Twenty-four-hour urine samples
were collected daily and, in addition, 6-day urine pools were
prepared for some measurements to minimize the number of
analyses. Morning fasting urine samples were obtained on 2
days during control and on 2 days during calcitriol administra-
tion to estimate fasting urinary Ca excretion and fasting
TmPO4/GFR. Blood specimens were drawn after fasting at 6
A.M. on 5 to 7 control days beginning at least 4 days after the
subjects started to eat the low Ca diet alone and on 6 to 10 days
beginning at least 4 days after calcitriol administration was
begun. The time of blood sampling was 6 hr after the last dose
and just before the next dose of calcitriol.
The analytical methods used for estimation of mineral and
TabIe 1. Fasting blood composition
Control Calcitriol pa
Number of subjects 4 4
l,25-(OH)2-D, M 94 l6' 209 35 <0.001
25-OH-D, nM 43 14 66 18 NS
Ca, m 2.45 0.07 2.44 0.05 NS
P04, mM 1.18 0.17 1.41 0.20 NS
iPTH, pJEq/ml 8.0 1.9 6.8 2.2 NS
Mg, m 0.93 0.06 0.88 0.05 NS
Creatinine, /SM 105 11 110 15 NS
a These values reflect the probability that observations during calci-
triol do not differ from control observations based on t test for unpaired
groups.b Values throughout the table are group means SD.
acid balances [9], iPTH [8], urinary hydroxyproline, and oxa-
late [8] have been previously reported. Urinary cAMP was
measured using a kit from Becton-Dickinson. Fasting
TmPO4/GFR was estimated from the Walton-Bijovet nomo-
gram [ii]. Vitamin D metabolites were measured by competi-
tive protein binding assay as previously reported [101. For the
measurement of 1 ,25-(OH)2-D, the interassay coefficient of
variation averaged 18% in a plasma pool measured in 36 assays
over the period during which the present studies were per-
formed. Normal values in 97 healthy adults eating ad lib average
89 25 SD M.
Results are presented as group means SD. Comparison of
the control subjects and the subjects given calcitriol were made
by analysis of variance for repeated measurements with time
[12]. Linear regressions were calculated by least squares.
Results
An overview: The problem of the steady state
Figure 1 shows the individual daily net intestinal Ca absorp-
tion, urinary Ca excretion, and Ca balance for each of the eight
subjects (the four subjects while eating the low Ca diet alone
and the four subjects studied while also taking calcitriol). It is
evident (Fig. 1) that average daily net intestinal Ca absorption
rose progressively during the first 6-day control period, reach-
ing an approximately stable level only during the second 6-day
control period. Similarly, daily urinary Ca excretion rose pro-
gressively during the first 10 days of calcitriol administration,
reaching a stable high rate only during the second and third 6-
day calcitriol balance periods. Because of these delays in
attaining the steady state during both the control and calcitriol
phases, we limited further analysis of the results to comparison
of the second 6-day control period to the second and third 6-day
calcitriol periods.
Steady state comparisons
Serum composition. Table I presents the measurements of
serum composition. During control, serum l,25-(OH)2-D levels
averaged 94 16 M in the four subjects adapted to the low
calcium diet and averaged 209 35 pM in the four subjects
eating the low calcium diet while receiving calcitriol. The mean
of the individual coefficients of variation for this measurement
averaged 25% for the subjects eating the low Ca diet alone and
16% for the subjects also receiving calcitriol. Serum 1,25-
(OH)2-D levels were stable in individual subjects as we have
observed previously [8]. There were no significant differences
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FIg. 1. Individual measurements of net intestinal Ca absorption, daily
urinary Ca excretion and Ca balance in the four subjects studied while
eating the low Ca diet alone (*, , A, •) and in the four subjects also
receiving calcitriol (*, •, •, *). See Results.
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Table 2. Body weights, daily dietary intake, fecal excretion, net
intestinal absorption, urinary excretion, and balances of Ca, P04,
and Mg
Control Calcitriol Pa
Number of subjects 4 4
Body weight, kg 71 1P 69 9 NS
Calcium diet, mmoleslday 4.0 0.2 4.2 0.9 NS
Feces 3.5 0.4 1.8 0.5 <0.001
Net intestinal absorption 0.5 0.3 2.4 0.7 <0.005
Urine 2.9 1.4 8.7 2.0 <0.005
Balance —2.4 1.2 —6.3 2.4 <0.05
P04 diet, mmoles!day 56.0 4.1 49.5 7.5 NS
Feces 14.1 2.0 11.7 2.1 NS
Net intestinal absorption 41.9 2.5 37.8 6.5 NS
Urine 34.2 2.7 38.9 6.1 NS
Balance +7.7 1.5 —1.1 5.4 NS
Mg diet, mmoleslday 17.8 0.6 17.1 1.8 NS
Feces 9.8 1.0 11.1 2.2 NS
Net intestinal absorption 8.0 0.5 6.0 1.8 NS
Urine 5.4 1.0 5.7 0.1 NS
Balance +2.6 0.7 +0.4 1.9 NS
Fecal wet weight, glday 83 16 100 7 NS
a These values reflect the probability that observations during calci-
tnol do not differ from control observations based on the analysis of
variance of repeated measurements with time.
Values throughout the table are group means sr.
in measured serum constituents although serum iPTH levels
tended to fall and serum P04 levels tended to be higher among
the subjects taking calcitriol.
Mineral balances
Table 2 presents mean body weight and the components of
the mineral balances for the subjects adapted to the low calcium
diet alone and the subjects observed during chronic calcitriol
administration.
Fecal calcium excretion was significantly lower in the group
receiving calcitriol, so that net intestinal calcium absorption
was significantly higher, averaging +0.5 0.3 mmoles/day or
12% of dietary calcium intake in the control studies and +2.4
0.7 mmoles/day or 57% of dietary calcium intake during calci-
triol. However, calcitriol administration increased urinary cal-
cium excretion strikingly to 8.7 mmoles/day. This very high
urinary calcium excretion rate during calcitriol administration
was 200% of dietary calcium intake. Thus, during calcitriol
administration, mean daily calcium balances were significantly
more negative than during the control studies (P < 0.05).
Neither fecal nor urinary phosphate excretion rates differed
significantly during calcitriol. Moreover mean daily P04 bal-
ances showed only an insignificant trend to become negative.
However, when the data for the subjects adapted to the low Ca
diet alone and the data for the subjects given calcitriol as well
were considered together, daily P04 balances were directly
correlated with daily calcium balances: P04 balance, mmoles!
day = 12.9 + 2.06 x Ca balance, mmoles!day; r = 0.84; P <
0.01.
Dietary Mg intake was very slightly lower for the subjects
given calcitriol, yet fecal Mg excretion tended to be higher
during calcitriol administration. However, neither mean net
intestinal Mg absorption, urinary Mg excretion nor daily Mg
balance differed during calcitriol as compared to control.
Table 3. Renal function, fasting urine composition, oxalate,
hydroxyproline excretion, and cAMP
Control Calcitriol Pa
Number of subjects 4b 4
Creatinine clearance, ml!
minll.73 m2 109 7 106 11 NS
Fasting urine Calcreatinine,
mmoleslmmole 0.17 0.05 0.48 0.19 <0.025
Fasting TmPO4/GFR, msi 1.24 0.22 1.32 0.19 NS
Fasting urine oxalate/creat-
me, mmoles/mmole 21 7 20 7 NS
Urine oxalate, mmoleslday 0.44 0.04 0.41 0.17 NS
Urine hydroxyproline,
mmoles/day 0.26 0.03 0.49 0.06 <0.001
Urine cAMP, mmoles/day 5.7 1.6 2.9 0.9 <0.025
a These values reflect the probability that observations during calci-
trio! do not differ from control observations based on t test for unpaired
groups.
b Values throughout the table are group means SD.
Sodium, potassium, chloride, and acid balances
During the control studies the daily balances of Na, K, and Cl
averaged +10 Il, +6 6, and +5 13 mmoles/day,
respectively, and were not significantly different for the sub-
jects observed during calcitriol administration, averaging + 13
5, +12 6, and +12 13 mmoles/day, respectively. For the
control studies blood pH, serum Na, K, Cl, and HCO3 averaged
7.40 0.02, 142 1, 4.2 0.1, 104 2, and 27.4 0.6,
respectively. These values were not different for the subjects
given calcitriol. Moreover endogenous fixed acid production,
renal net acid excretion and acid balance, which averaged 76
8, 68 7, and +8 4 mEq/day, respectively, during the control
studies were similar during calcitriol, averaging 69 16, 66
11, and +3 12 mEq!day, respectively.
Renal function, fasting urine composition, urinary oxalate,
and hydroxyproline excretion. As shown in Table 3, calcitriol
administration did not alter endogenous creatinine clearance,
taking into account the small differences in body size (Table 2)
and thus surface area of the two groups of subjects. Fasting
urinary calcium/creatinine and daily urinary hydroxyproline
excretion rates were strikingly higher among the subjects
receiving calcitriol. Neither mean fasting TmPO4!GFR, fasting
urine oxalate/creatinine, or daily urinary oxalate excretion were
detectably altered by calcitriol administration. Daily urinary
cAMP excretion was significantly lower during calcitriol
administration.
Relationships between Ca and P04 metabolism and hydroxy-
proline excretion and prevailing serum I ,25-(OH)2-D concen-
trations. As shown in Figure 2, individual net intestinal Ca
absorption and urinary Ca excretion rates were positively
correlated to prevailing serum l,25-(OH)2-D levels when the
data for the four subjects adapted to the low calcium diet alone
and the four subjects also given calcitriol were considered
together. Since urinary Ca excretion rose to a greater extent
than did net intestinal Ca absorption in the subjects given
calcitriol, Ca balance was inversely correlated to prevailing
serum 1 ,25-(OH)2-D levels. Daily P04 balances during control
and during calcitriol were also negatively correlated to serum
l,25-(OH)2-D levels: P04 balance, mmoles/day = 17.7 — 0.0907
x serum l,25-(OH)2-D, pM; r =
—0.89; P < 0.005.
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Fig. 2. Relationship between individual average daily net intestinal Ca
absorption (squares), average daily urinary Ca excretion (circles), and
average daily Ca balance (triangles) and individual serum 1,25-(OH)2-D
concentrations for the four subjects studied eating the low Ca diet alone
(open symbols) and the four subjects also receiving calcitriol (closed
symbols).
Figure 3 shows that urinary hydroxyproline excretion was
also directly correlated to prevailing serum 1 ,25-(OH)2-D levels
and was inversely correlated to daily Ca balances,
Fasting urine Ca/creatinine was also directly related to pre-
vailing serum 1 ,25-(OH)2-D levels, as we have observed previ-
ously [81: fasting urinary Calcreatinine, mmoles/mmole =
—0.10 + 0.00283 x serum l,25-(OH)2-D, pM; r 0.89; P <
0.005.
Discussion
Control conditions
Previous Ca balance studies have emphasized the time re-
quired to reach a steady state when healthy adults begin to eat a
lower Ca diet because of the delay in achieving maximally
efficient intestinal Ca absorption, that is, intestinal adaptation
[13]. To be sure that the control Ca balance data for our four
subjects indicated that they were adequately adapted to the low
Ca diet, we have compared our results to previously published
balance studies in healthy adults eating diets providing less than
6 mmoles Calday. We have selected studies of 25 healthy adults
(3 women and 22 men), older than 21 years to be sure skeletal
growth was complete, from eight publications [14—21]. Those
subjects were observed during balance periods beginning at
least 9 days after they had begun to eat their low Ca diet (range,
9 to 89 days). For these 25 subjects the components of Ca
balance averaged: diet 4.5 1.2, feces 5.2 1.6, net intestinal
absorption —0.7 1.6, urine 2.6 1.4, and balance —3.3 1.1
mmoles day, respectively. When these means are compared to
the cohesponding means for the control observations in our
four subjects (Table 2), only fecal Ca excretion was significantly
different in our subjects, being lower (P <0.05). This difference
was probably the result of a slightly lower average dietary Ca
intake and a slightly greater average net intestinal Ca absorption
among our volunteers. Thus, our subjects were at least as well
adapted to the low Ca diet as were the previously studied
subjects.
The effects of experimental elevation of serum 1,25-(OH)2-D
concentrations
Bone resorption. Since experimentally elevated serum 1,25-
(OH)2-D levels were accompanied by more negative Ca bal-
ances and a trend toward more negative P04 balances, augmen-
tation of daily urinary hydroxyproline excretion and fasting
hypercalciuria, we conclude that net bone resorption was
increased. Only the skeleton could provide a source for the
cumulative loss of an average of about 40 mmoles or 1.6 g of Ca
during the final 10 days of calcitriol administration (the differ-
ence in mean daily Ca balance between control and calcitriol
groups X 10 days, Table 2). These observations confirm in
humans the potent effect of 1 ,25-(OH)2-D to stimulate bone
resorption previously observed in animals and in cultured fetal
bone [6, 7].
Whether a higher dietary Ca intake, in the face of elevated
serum l,25-(OH)2-D levels, would prevent or reduce this effect
of I ,25-(OH)2-D to stimulate net bone resorption in healthy
subjects has not been studied. Speculatively, a higher dietary
Ca intake might not prevent such negative Ca balances. Support
for this view is derived from studies in patients with nephrolith-
iasis and hypercalciuria, many of whom exhibit high serum
l,25-(OH)2-D levels [3, 22, 23]. Balance studies in these pa-
tients, while they are eating diets providing 20 to 30 mmoles
Calday, show that they exhibit slightly but significantly nega-
tive Ca balances, while healthy subjects with normal serum
1 ,25-(OH)2-D levels eating comparable diets exhibit slightly but
significantly positive Ca balances [24, 25].
Mechanism of hypercalciuria. When serum l,25-(OH)2-D
concentrations were experimentally elevated, the resulting dai-
ly hypercalciuria (Fig. 2) and fasting hypercalciuria occurred
despite serum total Ca and iPTH concentrations which were
within the normal range (Table 1). It seems likely, however,
that subtle elevations of serum Ca concentrations and thus
glomerular filtration of Ca, as well as subtle reductions in iPTH
levels (as evidenced by the fall in urinary cAMP excretion) and
reduced renal tubular reabsorption of Ca, were both responsible
for the hypercalciuria. This explanation is based on our previ-
ous observations of a reciprocal rise in serum Ca and a fall in
iPTH concentrations when each subject given calcitriol served
as his own control and underwent multiple measurements of
serum Ca and iPTH throughout the day [8].
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Fig. 3. Relationships between individual
average daily urinary hydroxyproline excretion
and individual serum 1,25-(OH)2-D
concentrations (left panel) and individual
average daily Ca balances (right panel) for the
four subjects studied while eating the low Ca
diet alone (open symbols), and the four
subjects also receiving calcitriol (closed
symbols).
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These findings also confirm that neither elevated fasting urine
Ca/creatinine nor increased daily urine calcium excretion rates
provide evidence in themselves for a renal Ca leak during
prolonged dietary Ca deprivation when serum 1 ,25-(OH)2-D
levels are elevated. Documentation of a renal Ca leak would
require the additional demonstration of hypocalcemia and evi-
dence of secondary hyperparathyroidism.
In summary, these studies document that elevated serum
1 ,25-(OH)2-D levels in healthy men eating low Ca diets result in
net loss of bone. These observations may have relevance for the
care of patients with nephrolithiasis. Such patients may exhibit
elevated serum 1,25-(OH)2-D levels [3, 5, 26] and also may
exhibit reduced bone density [22, 24, 26, 27]. Speculatively,
therefore, the common recommendation that these patients
limit their dietary Ca intake may increase their long-term risk
for significant bone disease.
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